↓ Skip to main content

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib

Overview of attention for article published in Clinical Cancer Research, November 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Readers on

mendeley
172 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib
Published in
Clinical Cancer Research, November 2014
DOI 10.1158/1078-0432.ccr-14-1511
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Japan 1 <1%
United Kingdom 1 <1%
Unknown 170 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 41 24%
Student > Ph. D. Student 24 14%
Student > Master 21 12%
Other 14 8%
Student > Doctoral Student 12 7%
Other 29 17%
Unknown 31 18%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 40 23%
Biochemistry, Genetics and Molecular Biology 32 19%
Agricultural and Biological Sciences 20 12%
Pharmacology, Toxicology and Pharmaceutical Science 16 9%
Chemistry 11 6%
Other 10 6%
Unknown 43 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2026.
All research outputs
#1,237,945
of 31,634,113 outputs
Outputs from Clinical Cancer Research
#826
of 16,878 outputs
Outputs of similar age
#11,620
of 288,770 outputs
Outputs of similar age from Clinical Cancer Research
#9
of 174 outputs
Altmetric has tracked 31,634,113 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,878 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,770 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 174 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.